Loss of CD4 T-cell-dependent tolerance to proteins with modified amino acids - Wikidata - awgldk - TriplyDB

Loss of CD4 T-cell-dependent tolerance to proteins with modified amino acids

Loss of CD4 T-cell-dependent tolerance to proteins with modified amino acids

http://www.wikidata.org/entity/Q28243525

about

Inflammation-associated nitrotyrosination affects TCR recognition through reduced stability and alteration of the molecular surface of the MHC complex At the Interface of Chemical and Biological Synthesis: An Expanded Genetic Code.Coherent somatic mutation in autoimmune disease.Chemically modified peptides based on the membrane-proximal external region of the HIV-1 envelope induce high-titer, epitope-specific nonneutralizing antibodies in rabbits Retinal glycoprotein enrichment by concanavalin a enabled identification of novel membrane autoantigen synaptotagmin-1 in equine recurrent uveitis A single functional group substitution in c5a breaks B cell and T cell tolerance and protects against experimental arthritis.Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease.Antibody-recruiting molecules: an emerging paradigm for engaging immune function in treating human disease.Rational design of membrane proximal external region lipopeptides containing chemical modifications for HIV-1 vaccination.The histone deacetylase inhibitor SAHA induces HSP60 nitration and its extracellular release by exosomal vesicles in human lung-derived carcinoma cells.Understanding and applying tyrosine biochemical diversity.Therapeutic applications of an expanded genetic code.Unnatural amino acids in novel antibody conjugates.Exploring oxidative modifications of tyrosine: an update on mechanisms of formation, advances in analysis and biological consequences.Regulation of the Neurodegenerative Process Associated to Parkinson's Disease by CD4+ T-cells.Recent advances in the molecular design of synthetic vaccines.Immunogenicity of antibody drug conjugates: bioanalytical methods and monitoring strategy for a novel therapeutic modality.Playing with the molecules of life.Therapeutic applications of genetic code expansion

P2860

Q28481493-64D96CA5-EF48-4437-B716-93980736B1F2 Q30390524-011D38ED-DF95-4EC7-AD63-931C42777BE3 Q33837769-03D3561B-084B-473D-A6E3-EF6DC6806497 Q34057672-2B9B5799-A408-4895-92E9-3760D8D32A5B Q34510602-B40E5153-5AED-491C-A829-05D007D12C26 Q34998962-BAE23741-A0B4-4914-B9AB-BF648637B5FC Q35510197-642B57AF-B168-4C6E-B7BA-E2006B62C136 Q36108119-D65AF739-FCD9-437D-8931-EE0B7C0533B8 Q36504833-FBE8730C-FB01-4BC2-B820-2CCB98B6D1F9 Q37301688-07C23E20-3C43-42C4-A010-3FA6B34B3E22 Q38195522-A5B1CF55-4042-4447-9E16-B63FDEC78BD9 Q38232022-1EEF468D-DC16-47BE-8C4A-F06B48F7644A Q38243891-FEE3B6F2-DB6C-47AA-BD2F-C4F175CA5BA5 Q38392128-212467E8-ABDC-40AA-9E9E-CB34A491824B Q38505120-9728A7CD-04FF-455E-A667-AF2BB4A943FB Q38639938-AB1BCF29-3552-4C79-94C2-32D97E3F7D56 Q43096291-25BFA780-CD53-42F7-8168-61E36778CFC3 Q49968034-FEC55C07-AEB0-4B25-AE0C-66BDC1804F3B Q57818219-EC2F4C12-8E05-4B15-9CB2-8CC806BD9C2A

P2860

Loss of CD4 T-cell-dependent tolerance to proteins with modified amino acids

http://www.wikidata.org/entity/Q28243525

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Loss of CD4 T-cell-dependent tolerance to proteins with modified amino acids

@ast

Loss of CD4 T-cell-dependent tolerance to proteins with modified amino acids

@en

Loss of CD4 T-cell-dependent tolerance to proteins with modified amino acids

@nl

type

label

Loss of CD4 T-cell-dependent tolerance to proteins with modified amino acids

@ast

Loss of CD4 T-cell-dependent tolerance to proteins with modified amino acids

@en

Loss of CD4 T-cell-dependent tolerance to proteins with modified amino acids

@nl

prefLabel

Loss of CD4 T-cell-dependent tolerance to proteins with modified amino acids

@ast

Loss of CD4 T-cell-dependent tolerance to proteins with modified amino acids

@en

Loss of CD4 T-cell-dependent tolerance to proteins with modified amino acids

@nl

P1433

Q28243525-A42094BB-6712-462E-8EE4-3C6AF166E920

P1476

Q28243525-9684528C-4D53-41CF-BD36-7EEB652DCA71

P2093

Q28243525-07F5B20E-4791-468E-A543-EA877E50943F

Q28243525-0E64DFD3-4D81-4DD0-9507-83930F958561

Q28243525-2BA5DE11-A259-42EE-9A11-B3190FF14403

Q28243525-3AF002CD-56C0-4736-92BD-2B22719FEBF4

Q28243525-4213FADC-FB7F-49CF-ACD9-B8DEF5FA4BA4

Q28243525-4FEB3391-1E25-4E9B-BE14-4A51AECC145C

Q28243525-578D36D1-A285-42DE-8843-E30C8AF5856A

Q28243525-642D3DFB-C20B-4779-8878-266618768AB2

Q28243525-C3681721-8C6E-446A-96F5-3B08C66A5F9F

Q28243525-C8527788-34A6-4126-993C-EC268F0F81D9

P2860

Q28243525-07E7DDA8-CB16-4CAC-85B9-38EEA9A77B9A

Q28243525-09BCC558-9481-4611-BEED-ECF5F40C0B81

Q28243525-0D6F15C3-5D92-4B14-9CEA-F04DA9AF3F55

Q28243525-0DF18FA1-0303-442D-A704-2FB02D2E4056

Q28243525-0E41733E-4CFD-46D1-972B-4B9460094AA4

Q28243525-14398B2E-738C-46A6-A02E-1A18E4B05AE0

Q28243525-16BCFFA1-938E-4CA3-ABBB-5D9F9412FD38

Q28243525-17C42CDD-D44C-4DFA-BB8C-F60FB657F954

Q28243525-18677103-CC7D-4D4D-BA1C-CE81A0C0DDCB

Q28243525-1ADB1D3B-7EF9-4B44-B9FD-DFBBDDC14356

P304

Q28243525-131B05DD-61D9-4EF8-98F7-4795E0BA0798

P31

Q28243525-9B67D38D-09ED-467D-B4F0-15E3997345DB

P356

Q28243525-E981AE6F-97D6-4B3B-BDA6-AAB15DB91214

P407

Q28243525-D27868FE-6A36-41F4-8D5A-FBCCA177D579

P433

Q28243525-176FEBBF-A72F-4EF4-B476-432B8EA8242F

P478

Q28243525-BFF08468-13A9-45C3-B1F5-D956E33F428E

P577

Q28243525-AA91D65D-9622-4EA2-A897-D3067C8B9748

P5875

Q28243525-732BE0F0-2072-49B9-9D95-251013D320DE

P698

Q28243525-FE779005-1B65-4F44-9CC6-BA7C53FDDE73

P932

Q28243525-893C5EEF-C9F5-4FE9-AF8B-EB22106E9E3D

P356

PNAS.1110042108

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Loss of CD4 T-cell-dependent tolerance to proteins with modified amino acids

@en

P2093

Badry Bursulaya

http://www.w3.org/2001/XMLSchema#string

Bernhard H Geierstanger

http://www.w3.org/2001/XMLSchema#string

Christian Schmedt

http://www.w3.org/2001/XMLSchema#string

Jan Grünewald

http://www.w3.org/2001/XMLSchema#string

Lisa M Deaton

http://www.w3.org/2001/XMLSchema#string

Mingchao Kang

http://www.w3.org/2001/XMLSchema#string

Peter G Schultz

http://www.w3.org/2001/XMLSchema#string

Richard A Lerner

http://www.w3.org/2001/XMLSchema#string

Teresa Ramirez-Montagut

http://www.w3.org/2001/XMLSchema#string

Vanessa Gorney

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of MHC class II I-Ab in complex with a human CLIP peptide: prediction of an I-Ab peptide-binding motif

Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed self

Structural basis for the presentation of tumor-associated MHC class II-restricted phosphopeptides to CD4+ T cells

Granzyme B proteolysis of a neuronal glutamate receptor generates an autoantigen and is modulated by glycosylation

Oncogenic kinase signalling

The biology and enzymology of protein tyrosine O-sulfation

Two murine natural polyreactive autoantibodies are encoded by nonmutated germ-line genes

Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions

Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo

Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy

P304

12821-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1110042108

http://www.w3.org/2001/XMLSchema#string

P407

P433

31

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51501458

http://www.w3.org/2001/XMLSchema#string

P698

21768354

http://www.w3.org/2001/XMLSchema#string

P932

3150954

http://www.w3.org/2001/XMLSchema#string